Results 61 to 70 of about 95,683 (204)

β-Cell Mitochondria and Insulin Secretion

open access: yesDiabetes, 2002
The β-cell mitochondria are known to generate metabolic coupling factors, or messengers, that mediate plasma membrane depolarization and the increase in cytosolic Ca2+, the triggering event in glucose-stimulated insulin secretion. Accordingly, ATP closes nucleotide-sensitive K+ channels necessary for the opening of voltage-gated Ca2+ channels. ATP also
Claes B. Wollheim, Pierre Maechler
openaire   +2 more sources

Acromegaly: pathogenesis & treatment [PDF]

open access: yes, 2019
Acromegaly is a multi-system disorder whose etiology is most often traced back to a growth hormone-secreting pituitary adenoma (PA). Growth hormone (GH) secretion promotes insulin-like growth factor 1 (IGF-1) release from peripheral tissues, leading to ...
Tilvawala, Megha
core  

Mesenchymal Stem Cell Therapy in Type 1 Diabetes Mellitus and Its Main Complications: From Experimental Findings to Clinical Practice [PDF]

open access: yes, 2014
Type 1 diabetes mellitus (T1DM) is a complex multifactorial disorder which involves a loss of self-tolerance leading to the autoimmune destruction of pancreatic β−cells.
Arango Rodriguez, Martha   +3 more
core   +1 more source

Calbindin-D9k Ablation Disrupt Glucose/Pancreatic Insulin Homeostasis.

open access: yesPLoS ONE, 2016
It has been proposed that cellular Ca2+ signals activate hormone secretion. In pancreatic β cells, which produce insulin, Ca2+ signals have been known to contribute to insulin secretion.
Changhwan Ahn   +5 more
doaj   +1 more source

Vildagliptin Enhances Differentiation of Insulin Producing Cells from Adipose-Derived Mesenchymal Stem Cells

open access: yesCell Journal, 2018
Objective: Type 1 diabetes is caused by destruction of beta cells of pancreas. Vildagliptin (VG), a dipeptidyl peptidase IV (DPP IV) inhibitor, is an anti-diabetic drug, which increases beta cell mass.
Samaneh Karimi   +4 more
doaj   +1 more source

Reversal of hyperglycemia by insulin-secreting rat bone marrow- and blastocyst-derived hypoblast stem cell-like cells. [PDF]

open access: yesPLoS ONE, 2013
β-cell replacement may efficiently cure type 1 diabetic (T1D) patients whose insulin-secreting β-cells have been selectively destroyed by autoantigen-reactive T cells.
Anujith Kumar   +15 more
doaj   +1 more source

Characterization of prenylcysteine methyltransferase in insulin-secreting cells [PDF]

open access: yesBiochemical Journal, 1996
Prenylcysteine carboxymethyltransferase, an enzyme involved in the post-translational modification of many signalling proteins, was characterized in insulin-secreting INS-1 cells and normal rat pancreatic islets. The activity of this enzyme was monitored by the methylation of an artificial substrate (a prenylated cysteine analogue) with S-adenosyl ...
G, Li, A, Kowluru, S A, Metz
openaire   +2 more sources

Differentiation of human embryonic stem cells into insulin- secreting cells

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2006
Introduction: Type I diabetes mellitus is caused by autoimmune destruction of the insulin-producing β-cells. A new potential method for curing the disease is transplantation of differentiated insulin- secreting cells from human embryonic stem cells ...
S Mollamohammadi   +3 more
doaj  

Insulin secretion hot spots in pancreatic β cells as secreting adhesions

open access: yesFrontiers in Cell and Developmental Biology, 2023
Pancreatic β cell secretion of insulin is crucial to the maintenance of glucose homeostasis and prevention of diseases related to glucose regulation, including diabetes.
Margret A. Fye, Irina Kaverina
doaj   +1 more source

Inhibition of activin/nodal signalling is necessary for pancreatic differentiation of human pluripotent stem cells [PDF]

open access: yes, 2012
Peer reviewedPublisher ...
A Kubo   +42 more
core   +2 more sources

Home - About - Disclaimer - Privacy